• The Magazine
  • Advertising
  • NLS Member
  • About Us
  • Contact
  • Subscribe
  • Sign in
  • Pharma
  • Medtech
  • Biotech
  • Science
  • Events
  • Careers
  • Jobs
  • Opinion & Debate
  • The Magazine
  • Advertising
  • NLS Member
  • About Us
  • Contact
Menu
  • Subscribe
  • Sign in
Prio

Sign up

NLS

-

March 9, 2020

Share article on X
Share article on Linkedin


Published: March 9, 2020

Top stories

Biotech Business – August 21, 2026

Hansa Biopharma prepares for US listing

The company has announced confidential submission of draft registration statement to the SEC to allow for a potential listing of ADSs in the United States.

MedTech Business – August 21, 2026

Implantica receives FDA approval for RefluxStop

The FDA has granted Premarket Approval (PMA) for RefluxStop, the company’s implant-based treatment for gastroesophageal reflux disease (GERD).

Agreement – August 21, 2026

Akiram and ITM sign lutetium-177 supply agreement

Swedish biotech company Akiram Therapeutics has signed an agreement with ITM Isotope Technologies Munich to supply non-carrier-added lutetium-177 for the clinical development of AKIR001.

Financing – August 21, 2026

Eyedentity closes funding round led by Norrsken Launcher

Eyedentity, a company in the Karolinska Institutet Innovation Incubator, has closed an oversubscribed investment round led by Norrsken Launcher.
Follow NLS news
Follow us on XFollow us on LinkedinFollow us on Bluesky

Related posts

Acquisition - July 5, 2024

AddLife acquires BonsaiLab

AddLife acquires BonsaiLab, a Spanish distributor in the field of cell and molecular biology. The company, with current revenues of EUR 8 million, has operations in Spain and Portugal and will be included in AddLife’s business area Labtech. BonsaiLab will be included in the Biomedical and Research business unit, a part of the Labtech business […]

Prio - July 2, 2024

Senzime wins contract with children’s hospital in the US

Senzime has secured a purchasing contract with the number one ranked children’s hospital system in the United States for its TetraGraph quantitative neuromuscular monitoring system. The contract was awarded following a comprehensive competitive evaluation and once fully implemented, the TetraGraph system will be utilized in over 40 operating rooms, supporting more than 30,000 surgeries annually. […]

Business article - June 27, 2024

Senzime wins contract with children’s hospital in the US

Senzime has secured a purchasing contract with the number one ranked children’s hospital system in the United States for its TetraGraph quantitative neuromuscular monitoring system. The contract was awarded following a comprehensive competitive evaluation and once fully implemented, the TetraGraph system will be utilized in over 40 operating rooms, supporting more than 30,000 surgeries annually. […]

Prio - February 12, 2024

“I am optimistic that more female entrepreneurs will experience success in raising capital”

Nordic Life Science asked Lene Gerlach, Partner, Eir Ventures, about her predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you predict will be the dominant market trend within life sciences this year? “In the broader perspective, the market trend is steadily shifting towards prioritizing disease prevention over […]

In a new job - February 1, 2024

She will lead HiLIFE’s Neuroscience Center

Research Director Satu Palva has been appointed the new Director of the Neuroscience Center within Helsinki Institute of Life Science. Palva’s 5-year term started on February 1, 2024. According to Jari Koistinaho, Director of the Helsinki Institute of Life Sciences HiLIFE, Palva’s recruitment is an important step in further strengthening the life sciences portfolio of the […]

Careers article - December 13, 2023

My Nordic Corner: Helsinki

Jari Närhi, CEO of NADMED, describes the life science environment in Helsinki and shares his favorite spots. Describe the vibe in Helsinki for a company like yours! “Helsinki has wonderful tightly-knit startup and deep scientific communities that provide a great environment to develop novel, cutting-edge technologies and applications in biotech and medtech. The city is […]

Careers - November 27, 2023

My Nordic Life Science Corner: Odense

Thomas Kofoed, co-founder and CEO of Alphalyse, describes the life science environment in Odense and shares his favorite spots.

Sign up to our newsletter: Nordic Life Science News!

I confirm that I want to subscribe to newsletters from Nordic Life Science and that Nordic Life Science has the right to save my email address. Read our privacy policy here

Read the latest issue!

Sign up for a subscription and read our latest digital issue today.

Sign up
Sign up

The leading life science news channel in the Nordic region.

© NLS Media Group AB – All rights reserved

Digital and print
  • The magazine
  • Subscribe
  • Newsletter
More information
  • About us
  • Contact
  • Advertising
Social media
  • LinkedIn
  • Bluesky
  • X
NLS Media Group AB

St Paulsgatan 13

118 46 Sweden

info@nlsnews.com

+46-8-588 941 51

  • Cookies
  • Data management and privacy policy

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.